Afuco™ Anti-NGCGM3 ADCC Recombinant Antibody (Racotumomab), ADCC Enhanced (CAT#: AFC-TAB-H58)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant Mouse antibody to Human NGcGM3. Racotumomab (trade name Vaxira) is a therapeutic cancer vaccine for the treatment of solid tumors. It induces the patient's immune system to generate a response against a cancer-specific molecular target with the purpose of blocking tumor growth, slowing disease progression and ultimately increasing patient survival.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Datasheet
  • MSDS
  • COA

Specifications

  • Host Species
  • Mouse
  • Derivation
  • Mouse
  • Type
  • ADCC enhanced antibody
  • Specificity
  • idiotope of anti-(N-glycolylneuraminic acid (NeuGc, NGNA) -gangliosides GM3) Mus musculus IgM-kappa monoclonal antibody P3 [Homo sapiens]
  • Species Reactivity
  • Human
  • Clone
  • Racotumomab
  • Applications
  • FC, IP, ELISA, Neut, FuncS, IF
  • Conjugate
  • Unconjugated
  • Trade name
  • Vaxira
  • Generic Name
  • Racotumomab
  • Related Disease
  • Breast cancers

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • Racotumomab; vaxira; 946832-34-4; 1E10; N-glycolil (NGc) GM3; NGcGM3; NGNA ganglioside

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "racotumomab"

Anti-Human NGcGM3 Recombinant Antibody (Racotumomab)
Recombinant Mouse antibody to Human NGcGM3. Racotumomab (trade name Vaxira) is a therapeutic cancer vaccine for the treatment of solid tumors. It induces the patient's immune system to generate a response against a cancer-specific molecular target with the purpose of blocking tumor growth, slowing disease progression and ultimately increasing patient survival.

See other products for "NGcGM3"

Mouse Antibody

CAT Product Name Application Type
TAB-H58 Anti-Human NGcGM3 Recombinant Antibody (Racotumomab) Inhib, Agonist, Cyt, ELISA IgG1 - kappa

Recombinant Antibody

CAT Product Name Application Type
PABL-663 Human Anti-NGCGM3 Recombinant Antibody (clone chP3) ELISA Chimeric (mouse/human) IgG

Fab Fragment Antibody

CAT Product Name Application Type
PFBL-657 Human Anti-NGCGM3 Recombinant Antibody (clone chP3); Fab Fragment ELISA Chimeric (mouse/human) Fab

scFv Fragment Antibody

CAT Product Name Application Type
PSBL-657 Mouse Anti-NGCGM3 Recombinant Antibody (clone chP3); scFv Fragment ELISA Mouse scFv

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for AFC-TAB-H58. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare